I am interested in precision medicine and drug development. During my PhD and Postdoc period, I was trying to uncover mechanisms of cancer progression and develop anti-cancer agents. My current research work is focusing on developing antisense oligonucleotide (ASO) therapies for genetic disorders including frontotemporal dementia, Niemann-Pick disease type C, Rett syndrome, CDKL5 deficiency disorder, and Usher syndrome.